Dr. Reddy's Schedules Board Meeting on 23rd Oct'26 to Consider Q2 Results
Dr Reddys Laboratories Ltd 路 Intimation 路 23 Oct 2026, 5:30 am
Dr. Reddy's Schedules Board Meeting on 23rd Oct'26 to Consider Q2 Results Dr. Reddy鈥檚 Laboratories Limited announced that its Board of Directors will meet on 23rd Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ending 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in the company's securities will remain closed from 24th Sep'26 through 25th Oct'26 (both days inclusive).
Original exchange filing (PDF)
More announcements from Dr Reddys Laboratories Ltd
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 14 Nov 2026
- Intimation of Analyst meet 路 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 05 Nov 2026
- Allotment of Employee Stock options 路 04 Nov 2026
- Clarification - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) .... 路 03 Nov 2026
- Transcript of Earnings call 路 30 Oct 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 28 Oct 2026
